Haemonetics | HAE - Loan Capital


Haemonetics reported $1.22B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Avanos Medical USD 87.3M 3M Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Cerus USD 64.86M 22K Dec/2024
Cooper Companies USD 1.86B 17.7M Mar/2026
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 1.22B 299.58M Mar/2026
ICU Medical USD 1.26B 4.09M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Quidel USD 0 2.47B Mar/2026
ResMed USD 404.17M 245K Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Steris USD 1.81B 85.6M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Terumo JPY 99.91B 13M Mar/2026
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
US Physical Therapy USD 194.04M 41.45M Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026